Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"
Director TitleAgeSince
Director/Board Member - -
Director/Board Member - 2013-09-26
Chairman - -
Change 5-day change 1-year change 3-year change Capi.($)
+1.25%-20.59% - - 23.15M
-0.34%-0.08%-12.15%-13.39% 43.44B
+3.31%+9.22%+308.19%+562.02% 33.54B
+2.84%+3.80%+6.87%+34.93% 29.2B
-1.70%-7.34%+8.51%-22.34% 28.48B
-0.57%+4.45%+12.31%+20.42% 25.34B
-0.14%+7.06% - - 14.36B
+0.68%-3.13%+52.04%+107.47% 13.05B
+0.54%-2.27%+3.93%+2.24% 12.67B
-0.26%+0.41%+100.27%+80.69% 12.28B
Average +0.56%+1.38%+60.00%+96.51% 23.6B
Weighted average by Cap. +0.60%+1.40%+63.25%+109.05%
Logo Pharmadax Inc.
Pharmadax Inc is a Taiwan-based company principally engaged in the development, licensing and sales of Abbreviated New Drug Application (ANDA) drugs. The Company is mainly engaged in the development of oral solid extended-release dosage forms and products. The Company's main product is the hypoglycemic product, Glyburide. The Company distributes its products to the United States.
Employees
-
  1. Stock Market
  2. Stocks
  3. 4191 Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!